478 related articles for article (PubMed ID: 22374203)
1. Omalizumab inhibits acceleration of FcεRI-mediated responsiveness of immature human mast cells by immunoglobulin E.
Okayama Y; Kashiwakura J; Sasaki-Sakamoto T; Matsumoto K; Hashimoto N; Ohmori K; Kawakami T; Saito H; Ra C
Ann Allergy Asthma Immunol; 2012 Mar; 108(3):188-94. PubMed ID: 22374203
[TBL] [Abstract][Full Text] [Related]
2. FcepsilonRI-alpha siRNA inhibits the antigen-induced activation of mast cells.
Safaralizadeh R; Soheili ZS; Deezagi A; Pourpak Z; Samiei S; Moin M
Iran J Allergy Asthma Immunol; 2009 Dec; 8(4):177-83. PubMed ID: 20404387
[TBL] [Abstract][Full Text] [Related]
3. Regulation of IgE-dependent zinc release from human mast cells.
Nakashima-Kaneda K; Matsuda A; Mizuguchi H; Sasaki-Sakamoto T; Saito H; Ra C; Okayama Y
Int Arch Allergy Immunol; 2013; 161 Suppl 2():44-51. PubMed ID: 23711853
[TBL] [Abstract][Full Text] [Related]
4. The potential pharmacologic mechanisms of omalizumab in patients with chronic spontaneous urticaria.
Chang TW; Chen C; Lin CJ; Metz M; Church MK; Maurer M
J Allergy Clin Immunol; 2015 Feb; 135(2):337-42. PubMed ID: 24948369
[TBL] [Abstract][Full Text] [Related]
5. Histamine receptor H4 regulates mast cell degranulation and IgE induced FcεRI upregulation in murine bone marrow-derived mast cells.
Mirzahosseini A; Dalmadi B; Csutora P
Cell Immunol; 2013; 283(1-2):38-44. PubMed ID: 23850674
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of human cord blood-derived mast cell responses by anti-Fc epsilon RI mAb 15/1 versus anti-IgE Omalizumab.
Mirkina I; Schweighoffer T; Kricek F
Immunol Lett; 2007 Apr; 109(2):120-8. PubMed ID: 17368811
[TBL] [Abstract][Full Text] [Related]
7. Cultured human mast cells are heterogeneous for expression of the high-affinity IgE receptor FcεRI.
Hoffmann HJ; Frandsen PM; Christensen LH; Schiøtz PO; Dahl R
Int Arch Allergy Immunol; 2012; 157(3):246-50. PubMed ID: 22042057
[TBL] [Abstract][Full Text] [Related]
8. An anti-IgE monoclonal antibody that binds to IgE on CD23 but not on high-affinity IgE.Fc receptors.
Shiung YY; Chiang CY; Chen JB; Wu PC; Hung AF; Lu DC; Pan RL; Chang TW
Immunobiology; 2012 Jul; 217(7):676-83. PubMed ID: 22226669
[TBL] [Abstract][Full Text] [Related]
9. The interaction between Lyn and FcεRIβ is indispensable for FcεRI-mediated human mast cell activation.
Okayama Y; Kashiwakura JI; Matsuda A; Sasaki-Sakamoto T; Nunomura S; Yokoi N; Ebihara N; Kuroda K; Ohmori K; Saito H; Ra C
Allergy; 2012 Oct; 67(10):1241-9. PubMed ID: 22845063
[TBL] [Abstract][Full Text] [Related]
10. Omalizumab treatment downregulates dendritic cell FcepsilonRI expression.
Prussin C; Griffith DT; Boesel KM; Lin H; Foster B; Casale TB
J Allergy Clin Immunol; 2003 Dec; 112(6):1147-54. PubMed ID: 14657874
[TBL] [Abstract][Full Text] [Related]
11. Anti-IgE as a mast cell-stabilizing therapeutic agent.
Chang TW; Shiung YY
J Allergy Clin Immunol; 2006 Jun; 117(6):1203-12; quiz 1213. PubMed ID: 16750976
[TBL] [Abstract][Full Text] [Related]
12. A bispecific antibody against human IgE and human FcgammaRII that inhibits antigen-induced histamine release by human mast cells and basophils.
Tam SW; Demissie S; Thomas D; Daëron M
Allergy; 2004 Jul; 59(7):772-80. PubMed ID: 15180766
[TBL] [Abstract][Full Text] [Related]
13. Reduction of total IgE by targeted coengagement of IgE B-cell receptor and FcγRIIb with Fc-engineered antibody.
Chu SY; Horton HM; Pong E; Leung IW; Chen H; Nguyen DH; Bautista C; Muchhal US; Bernett MJ; Moore GL; Szymkowski DE; Desjarlais JR
J Allergy Clin Immunol; 2012 Apr; 129(4):1102-15. PubMed ID: 22257644
[TBL] [Abstract][Full Text] [Related]
14. Accelerated dissociation of IgE-FcεRI complexes by disruptive inhibitors actively desensitizes allergic effector cells.
Eggel A; Baravalle G; Hobi G; Kim B; Buschor P; Forrer P; Shin JS; Vogel M; Stadler BM; Dahinden CA; Jardetzky TS
J Allergy Clin Immunol; 2014 Jun; 133(6):1709-19.e8. PubMed ID: 24642143
[TBL] [Abstract][Full Text] [Related]
15. An immunoglobulin E-reactive chimeric human immunoglobulin G1 anti-idiotype inhibits basophil degranulation through cross-linking of FcepsilonRI with FcgammaRIIb.
Wigginton SJ; Furtado PB; Armour KL; Clark MR; Robins A; Emara M; Ghaemmaghami AM; Sewell HF; Shakib F
Clin Exp Allergy; 2008 Feb; 38(2):313-9. PubMed ID: 18070161
[TBL] [Abstract][Full Text] [Related]
16. Mast cells express IL-13R alpha 1: IL-13 promotes human lung mast cell proliferation and Fc epsilon RI expression.
Kaur D; Hollins F; Woodman L; Yang W; Monk P; May R; Bradding P; Brightling CE
Allergy; 2006 Sep; 61(9):1047-53. PubMed ID: 16918506
[TBL] [Abstract][Full Text] [Related]
17. Human mast cell line-1 (HMC-1) cells transfected with FcεRIα are sensitive to IgE/antigen-mediated stimulation demonstrating selectivity towards cytokine production.
Xia YC; Sun S; Kuek LE; Lopata AL; Hulett MD; Mackay GA
Int Immunopharmacol; 2011 Aug; 11(8):1002-11. PubMed ID: 21356342
[TBL] [Abstract][Full Text] [Related]
18. Treatment of chronic autoimmune urticaria with omalizumab.
Kaplan AP; Joseph K; Maykut RJ; Geba GP; Zeldin RK
J Allergy Clin Immunol; 2008 Sep; 122(3):569-73. PubMed ID: 18774392
[TBL] [Abstract][Full Text] [Related]
19. A high-affinity monoclonal anti-IgE antibody for depletion of IgE and IgE-bearing cells.
Laffer S; Lupinek C; Rauter I; Kneidinger M; Drescher A; Jordan JH; Krauth MT; Valent P; Kricek F; Spitzauer S; Englund H; Valenta R
Allergy; 2008 Jun; 63(6):695-702. PubMed ID: 18325077
[TBL] [Abstract][Full Text] [Related]
20. Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.
Holgate ST; Djukanović R; Casale T; Bousquet J
Clin Exp Allergy; 2005 Apr; 35(4):408-16. PubMed ID: 15836747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
